Drug Type CAR-T |
Synonyms- |
Target |
Action inhibitors |
Mechanism CD72 inhibitors(CD72 molecule inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Preclinical | United States | 11 Dec 2022 | |
Acute Lymphoblastic Leukemia | Preclinical | United States | 11 Dec 2022 |